The Systemic Immune-Inflammation Index (SII) Increases the Prognostic Significance of Lymphovascular Invasion in Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA. 2019;69(1):7–34. doi:10.3322/caac.21551
   Web of Science ®Google Scholar
• Shen CH, Chiou HY, Tung MC, et al. Clinical and demographic characteristics among patients with urothelial carcinomas of the upper urinary tract and bladder in Taiwan. J Chin Med Assoc. 2017;80(9):563–568. doi:10.1016/j.jcma.2017.03.008
   PubMed Web of Science ®Google Scholar
• Roupret M, Babjuk M, Burger M, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol. 2021;79(1):62–79. doi:10.1016/j.eururo.2020.05.042
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network. Bladder cancer; 2022. Available from: https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf. Accessed May 20, 2022.
   Google Scholar
• Novara G, Matsumoto K, Kassouf W, et al. Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol. 2010;57(6):1064–1071. doi:10.1016/j.eururo.2009.12.029
   PubMed Web of Science ®Google Scholar
• Kikuchi E, Margulis V, Karakiewicz PI, et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol. 2009;27(4):612–618. doi:10.1200/JCO.2008.17.2361
   PubMed Web of Science ®Google Scholar
• Sung SY, Kwak YK, Lee SW, et al. Lymphovascular invasion increases the risk of nodal and distant recurrence in node-negative stage I-IIA non-small-cell lung cancer. Oncology. 2018;95(3):156–162. doi:10.1159/000488859
   PubMed Web of Science ®Google Scholar
• Rakha EA, Martin S, Lee AH, et al. The prognostic significance of lymphovascular invasion in invasive breast carcinoma. Cancer. 2012;118(15):3670–3680. doi:10.1002/cncr.26711
   PubMed Web of Science ®Google Scholar
• Kang YJ, Kim HS, Jang WS, et al. Impact of lymphovascular invasion on lymph node metastasis for patients undergoing radical prostatectomy with negative resection margin. BMC Cancer. 2017;17(1):321. doi:10.1186/s12885-017-3307-4
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi:10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493–e503. doi:10.1016/S1470-2045(14)70263-3
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature07205
   PubMed Web of Science ®Google Scholar
• Jan HC, Yang WH, Ou CH. Combination of the preoperative systemic immune-inflammation index and monocyte-lymphocyte ratio as a novel prognostic factor in patients with upper-tract urothelial carcinoma. Ann Surg Oncol. 2019;26(2):669–684. doi:10.1245/s10434-018-6942-3
   PubMed Web of Science ®Google Scholar
• Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212–6222. doi:10.1158/1078-0432.CCR-14-0442
   PubMed Web of Science ®Google Scholar
• Zheng L, Zou K, Yang C, Chen F, Guo T, Xiong B. Inflammation-based indexes and clinicopathologic features are strong predictive values of preoperative circulating tumor cell detection in gastric cancer patients. Clin Transl Oncol. 2017;19(9):1125–1132. doi:10.1007/s12094-017-1649-7
   PubMed Web of Science ®Google Scholar
• Yang R, Chang Q, Meng X, Gao N, Wang W. Prognostic value of Systemic immune-inflammation index in cancer: a meta-analysis. J Cancer. 2018;9(18):3295–3302. doi:10.7150/jca.25691
   PubMed Web of Science ®Google Scholar
• Barresi V, Reggiani Bonetti L, Vitarelli E, Di Gregorio C, Ponz de Leon M, Barresi G. Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases. Am J Surg Pathol. 2012;36(1):66–72. doi:10.1097/PAS.0b013e31822d3008
   PubMed Web of Science ®Google Scholar
• Aleskandarany MA, Sonbul SN, Mukherjee A, Rakha EA. Molecular mechanisms underlying lymphovascular invasion in invasive breast cancer. Pathobiology. 2015;82(3–4):113–123. doi:10.1159/000433583
   PubMed Web of Science ®Google Scholar
• Bolenz C, Fernandez MI, Trojan L, et al. Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis. BJU Int. 2009;103(8):1040–1046. doi:10.1111/j.1464-410X.2008.08135.x
   PubMed Web of Science ®Google Scholar
• Liu W, Sun L, Guan F, Wang F, Zhang G. Prognostic value of lymphovascular invasion in upper urinary tract urothelial carcinoma after radical nephroureterectomy: a systematic review and meta-analysis. Dis Markers. 2019;2019:7386140. doi:10.1155/2019/7386140
   PubMed Web of Science ®Google Scholar
• Ku JH, Byun SS, Jeong H, Kwak C, Kim HH, Lee SE. Lymphovascular invasion as a prognostic factor in the upper urinary tract urothelial carcinoma: a systematic review and meta-analysis. Eur J Cancer. 2013;49(12):2665–2680. doi:10.1016/j.ejca.2013.04.016
   PubMed Web of Science ®Google Scholar
• Zhang L, Wu B, Zha Z, Zhao H, Yuan J, Feng Y. The prognostic value of lymphovascular invasion in patients with upper tract urinary carcinoma after surgery: an updated systematic review and meta-analysis. Front Oncol. 2020;10:487. doi:10.3389/fonc.2020.00487
   PubMed Web of Science ®Google Scholar
• Godfrey MS, Badalato GM, Hruby GW, Razmjoo M, McKiernan JM. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion. BJU Int. 2012;110(6):798–803. doi:10.1111/j.1464-410X.2011.10893.x
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–867. doi:10.1038/nature01322
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883–899. doi:10.1016/j.cell.2010.01.025
   PubMed Web of Science ®Google Scholar
• Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168(4):670–691. doi:10.1016/j.cell.2016.11.037
   PubMed Web of Science ®Google Scholar
• Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis. 2003;6(4):283–287. doi:10.1023/B:AGEN.0000029415.62384.ba
   PubMedGoogle Scholar
• Mori K, Resch I, Miura N, et al. Prognostic role of the systemic immune-inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration. Cancer Immunol Immunother. 2021;70(9):2641–2650. doi:10.1007/s00262-021-02884-w
   PubMed Web of Science ®Google Scholar
• Colla Ruvolo C, Wenzel M, Nocera L, et al. The effect of race on stage at presentation and survival in upper tract urothelial carcinoma. Urol Oncol. 2021;39(11):788 e7–e13. doi:10.1016/j.urolonc.2021.07.001
   PubMed Web of Science ®Google Scholar